drugset / Trial / NCT06178874
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The role of ultralong insulin in the control of the blood glucose level in diabetic patients is well known, the current study will discuss the role of ultralong insulin in controlling of hyperglycaemia in critical illness defined as failure or impending failure of an organ
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-05-25
- Completion
- 2024-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin degludec | Protein / enzyme biologic | 0.2 iu/kg | Subcutaneous |
| Comparator | insulin glargine | Protein / enzyme biologic | 0.2 iu/kg | Subcutaneous |
| Comparator | Insulin regular | Unknown | — | Intravenous |